112 related articles for article (PubMed ID: 23919244)
1. Synthesis and biological evaluation of α-galactosylceramide analogues with heteroaromatic rings and varying positions of a phenyl group in the sphingosine backbone.
Kim Y; Oh K; Song H; Lee DS; Park SB
J Med Chem; 2013 Sep; 56(17):7100-9. PubMed ID: 23919244
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological activity of hydroxylated analogues of KRN7000 (α-galactosylceramide).
Shiozaki M; Tashiro T; Koshino H; Shigeura T; Watarai H; Taniguchi M; Mori K
Carbohydr Res; 2013 Apr; 370():46-66. PubMed ID: 23454137
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of alpha-galactosyl ceramide (KRN7000) and analogues thereof via a common precursor and their preliminary biological assessment.
Michieletti M; Bracci A; Compostella F; De Libero G; Mori L; Fallarini S; Lombardi G; Panza L
J Org Chem; 2008 Nov; 73(22):9192-5. PubMed ID: 18956839
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of truncated analogues of the iNKT cell agonist, α-galactosyl ceramide (KRN7000), and their biological evaluation.
Veerapen N; Reddington F; Salio M; Cerundolo V; Besra GS
Bioorg Med Chem; 2011 Jan; 19(1):221-8. PubMed ID: 21145749
[TBL] [Abstract][Full Text] [Related]
5. Induction of Th1-biased cytokine production by alpha-carba-GalCer, a neoglycolipid ligand for NKT cells.
Tashiro T; Sekine-Kondo E; Shigeura T; Nakagawa R; Inoue S; Omori-Miyake M; Chiba T; Hongo N; Fujii S; Shimizu K; Yoshiga Y; Sumida T; Mori K; Watarai H; Taniguchi M
Int Immunol; 2010 Apr; 22(4):319-28. PubMed ID: 20181652
[TBL] [Abstract][Full Text] [Related]
6. Focus on the controversial activation of human iNKT cells by 4-deoxy analogue of KRN7000.
Lacône V; Hunault J; Pipelier M; Blot V; Lecourt T; Rocher J; Turcot-Dubois AL; Marionneau S; Douillard JY; Clément M; Le Pendu J; Bonneville M; Micouin L; Dubreuil D
J Med Chem; 2009 Aug; 52(15):4960-3. PubMed ID: 19580320
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological activity of ester and ether analogues of alpha-galactosylceramide (KRN7000).
Shiozaki M; Tashiro T; Koshino H; Nakagawa R; Inoue S; Shigeura T; Watarai H; Taniguchi M; Mori K
Carbohydr Res; 2010 Aug; 345(12):1663-84. PubMed ID: 20591421
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of RCAI-172 (C6 epimer of RCAI-147) and its biological activity.
Shiozaki M; Tashiro T; Koshino H; Shigeura T; Watarai H; Taniguchi M; Mori K
Bioorg Med Chem; 2014 Jan; 22(2):827-33. PubMed ID: 24360828
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of alpha-galactosylceramide (KRN7000) and isoglobotrihexosylceramide (iGb3).
Xia C; Yao Q; Schümann J; Rossy E; Chen W; Zhu L; Zhang W; De Libero G; Wang PG
Bioorg Med Chem Lett; 2006 Apr; 16(8):2195-9. PubMed ID: 16458002
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and Th1-immunostimulatory activity of α-galactosylceramide analogues bearing a halogen-containing or selenium-containing acyl chain.
Hossain MI; Hanashima S; Nomura T; Lethu S; Tsuchikawa H; Murata M; Kusaka H; Kita S; Maenaka K
Bioorg Med Chem; 2016 Aug; 24(16):3687-95. PubMed ID: 27325450
[TBL] [Abstract][Full Text] [Related]
11. 3-fluoro- and 3,3-difluoro-3,4-dideoxy-KRN7000 analogues as new potent immunostimulator agents: total synthesis and biological evaluation in human invariant natural killer T cells and mice.
Hunault J; Diswall M; Frison JC; Blot V; Rocher J; Marionneau-Lambot S; Oullier T; Douillard JY; Guillarme S; Saluzzo C; Dujardin G; Jacquemin D; Graton J; Le Questel JY; Evain M; Lebreton J; Dubreuil D; Le Pendu J; Pipelier M
J Med Chem; 2012 Feb; 55(3):1227-41. PubMed ID: 22243602
[TBL] [Abstract][Full Text] [Related]
12. Heteroaromatic Moieties in the Sphingosine Backbone of α-Galactosylceramides for Noncovalent Interactions with CD1d.
Kim Y; Kim J; Oh K; Lee DS; Park SB
ACS Med Chem Lett; 2012 Feb; 3(2):151-4. PubMed ID: 24900444
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of an alpha-C-galactosylceramide analogue that induces Th1-biased responses in human natural killer T cells.
Lu X; Song L; Metelitsa LS; Bittman R
Chembiochem; 2006 Nov; 7(11):1750-6. PubMed ID: 17009272
[TBL] [Abstract][Full Text] [Related]
14. 4"-O-Alkylated α-Galactosylceramide Analogues as iNKT-Cell Antigens: Synthetic, Biological, and Structural Studies.
Janssens J; Bitra A; Wang J; Decruy T; Venken K; van der Eycken J; Elewaut D; Zajonc DM; van Calenbergh S
ChemMedChem; 2019 Jan; 14(1):147-168. PubMed ID: 30556652
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of sphinganine analogues of KRN7000 and OCH.
Ndonye RM; Izmirian DP; Dunn MF; Yu KO; Porcelli SA; Khurana A; Kronenberg M; Richardson SK; Howell AR
J Org Chem; 2005 Dec; 70(25):10260-70. PubMed ID: 16323834
[TBL] [Abstract][Full Text] [Related]
16. An α-GalCer analogue with branched acyl chain enhances protective immune responses in a nasal influenza vaccine.
Lee YS; Lee KA; Lee JY; Kang MH; Song YC; Baek DJ; Kim S; Kang CY
Vaccine; 2011 Jan; 29(3):417-25. PubMed ID: 21087689
[TBL] [Abstract][Full Text] [Related]
17. Production of both IL-27 and IFN-gamma after the treatment with a ligand for invariant NK T cells is responsible for the suppression of Th2 response and allergic inflammation in a mouse experimental asthma model.
Fujita H; Teng A; Nozawa R; Takamoto-Matsui Y; Katagiri-Matsumura H; Ikezawa Z; Ishii Y
J Immunol; 2009 Jul; 183(1):254-60. PubMed ID: 19542437
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of acyl-chain- and galactose-6''-modified analogues of α-GalCer for NKT cell activation.
Hsieh MH; Hung JT; Liw YW; Lu YJ; Wong CH; Yu AL; Liang PH
Chembiochem; 2012 Jul; 13(11):1689-97. PubMed ID: 22730199
[TBL] [Abstract][Full Text] [Related]
19. Activation of human invariant natural killer T cells with a thioglycoside analogue of α-galactosylceramide.
Hogan AE; O'Reilly V; Dunne MR; Dere RT; Zeng SG; O'Brien C; Amu S; Fallon PG; Exley MA; O'Farrelly C; Zhu X; Doherty DG
Clin Immunol; 2011 Aug; 140(2):196-207. PubMed ID: 21493160
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of 1,2,3-triazole containing analogues of the immunostimulant alpha-GalCer.
Lee T; Cho M; Ko SY; Youn HJ; Baek DJ; Cho WJ; Kang CY; Kim S
J Med Chem; 2007 Feb; 50(3):585-9. PubMed ID: 17266209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]